Improved quality of diabetes control reduces complication costs in Bulgaria

References

• Ministry of Health. Guidelines for good clinical practice in Diabetes Mellitus. Sofia (Bulgaria): Bulgarian Endocrinology Society; 2016 [cited 2018 Dec 20]. Bulgarian. Available from: http://endo-bg.com/wp-content/uploads/2016/04/DIABET-2016-new.pdf
   Google Scholar
• Zimmet PZ, Magliano DJ, Herman WH, et al. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2:56–64.
   PubMed Web of Science ®Google Scholar
• WHO. Global status report on noncommunicable diseases. 2014. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
   Google Scholar
• European parliament resolution from 14 March 2012 regarding countermeasures against the diabetes epidemic in the EU [cited 2018 Dec 20]. Available from: http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//NONSGML+TA+P7-TA-2012-0082+0+DOC+PDF+V0//BG
   Google Scholar
• Bulgarian Diabetes Association. Memorandum on limiting the incidence of Diabetes Mellitus in Bulgaria; 2008. Available from: http://www.badiabet.com/index.php?option=com_content&view=article&id=63%3A
   Google Scholar
• Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373:1720–1732.
   PubMed Web of Science ®Google Scholar
• Gaede P, Lund-Andersen H, Parving H-H, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–591.
   PubMed Web of Science ®Google Scholar
• Miller RG, Secrest AM, Sharma RK, et al. Improvements in the life expectancy of Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes. 2012;61:2987–2992.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Beckles GL, Williamson DF, et al. Diabetes and physical disability among older U.S. adults. Diabetes Care. 2000;23:1272–1277.
   PubMed Web of Science ®Google Scholar
• Wong E, Backholer K, Gearon E, et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013;1:106–114.
   PubMed Web of Science ®Google Scholar
• Gale EAM. The United Kingdom Prospective Diabetes Study [UKPDS] [internet]. [cited 2014 Oct 20]; Diapedia 1104085197 rev. no. 20. Available from: https://doi.org/10.14496/dia.1104085197.20
   Google Scholar
• Stratton IM, Adler AI, Neil AHW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405.
   PubMed Web of Science ®Google Scholar
• Ostrowska J, Jakubczyk M, Niewada M, et al. Estimating the cost of diabetes related cardiovascular complications in selected Central and Eastern European countries. Value Health. 2017;20:A476.
   Web of Science ®Google Scholar
• Ministry of Health of Bulgaria. Decision № RD-NS-04-24-1 from March 29th 2016 г. under section 54, paragraphs 9 and 59а, sub-paragraph 6 of the Health Insurance law by the Council of oversight to the National Health Insurance Fund (NHIF), State Gazette 25/31.03.2016. Bulgarian.
   Google Scholar
• Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–229.
   PubMed Web of Science ®Google Scholar
• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–149.
   PubMed Web of Science ®Google Scholar
• Stolar MW. Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85:S50–S59.
   PubMedGoogle Scholar
• Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care. 2015;38:1449–1455.
   PubMed Web of Science ®Google Scholar
• Norhammar A, Bodegard J, Nyström T, et al. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013. Diabetologia. 2016;59:1692–1701.
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20:546–551.
   PubMedGoogle Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316.
   PubMed Web of Science ®Google Scholar
• de Pablos-Velasco P, Parhofer K, et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study. Clin Endocrinol. 2014;80:47–56.
   PubMed Web of Science ®Google Scholar
• Cokolic M, Lalic N, Micic D, et al. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania. Wien Klin Wochenschr. 2017;129:192–200.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. New Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New Engl J Med. 2005;353:2643–2653.
   PubMed Web of Science ®Google Scholar
• Martin CL, Albers GW, Pop-Busui R. DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37:31–38.
   PubMed Web of Science ®Google Scholar
• The DCCT/EDIC Research Group, Aiello LP, Sun W, et al. Intensive diabetes therapy and ocular surgery in type 1 diabetes. New Engl J Med. 2015;372:1722–1733.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetes retinopathy: XVII, The 14 years incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophtalmology. 1998;105:1801–1815.
   PubMed Web of Science ®Google Scholar